Picture of Kuros Biosciences AG logo

KURN — Kuros Biosciences AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Kuros Biosciences Reports First Patient Treated In Randomized Controlled Trial Of MagnetOs In Spinal Fusion

Sept 27 (Reuters) - Kuros Biosciences AG  KURN.S :
    * REPORTS FIRST PATIENT TREATED IN RANDOMIZED CONTROLLED
TRIAL OF
MAGNETOS IN SPINAL FUSION

Source text for Eikon:  ID:nTENih5tya 
Further company coverage:  KURN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Kuros Biosciences AG

See all news